0001209191-18-035379.txt : 20180604
0001209191-18-035379.hdr.sgml : 20180604
20180604200703
ACCESSION NUMBER: 0001209191-18-035379
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170531
FILED AS OF DATE: 20180604
DATE AS OF CHANGE: 20180604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAVIGNE LOUIS J JR
CENTRAL INDEX KEY: 0001214127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 18879769
MAIL ADDRESS:
STREET 1: C/O ALLERGAN, INC.
STREET 2: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-31
0
0001645113
NovoCure Ltd
NVCR
0001214127
LAVIGNE LOUIS J JR
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
1
0
0
0
Options to Buy Ordinary Shares
31.45
2018-05-31
4
A
0
12345
0.00
A
2028-05-31
Ordinary Shares
12345
12345
D
Restricted Stock Unit
2018-05-31
4
A
0
6145
0.00
A
Ordinary Shares
6145
6145
D
Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders.
Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.
These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders.
By: /s/ Kimberly Burke, Attorney in fact for Louis J. Lavigne, Jr.
2018-06-04
EX-24.4_794159
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING PURPOSES
Know all by these presents, that the undersigned hereby makes, constitutes and
appoints Todd Longsworth, Kimberly Burke and Carrie Kane, acting individually,
as the undersigned's true and lawful attorneys-in-fact, with full power and
authority as hereinafter described on behalf of and in the name, place and stead
of the undersigned to:
(1) execute for, and on behalf of, the undersigned, in the undersigned's
capacity as an officer, director and/or 10% beneficial owner of Novocure Limited
(the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder (the "Exchange Act");
(2) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's securities
from any third party, including brokers, employee benefit plan administrators
and trustees, and the undersigned hereby authorizes any such person to release
any such information to any attorneys-in-fact and further approves and ratifies
any such release of information;
(3) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to prepare, complete and execute any such Form 3,
4 or 5, and any amendments thereto, or other required report and timely file
such Forms or reports with the United States Securities and Exchange Commission,
the New York Stock Exchange and any stock exchange or similar authority as
considered necessary or advisable under Section 16(a) of the Exchange Act; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorneys-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorneys-in-fact on behalf of
the undersigned pursuant to this Limited Power of Attorney shall be in such form
and shall contain such terms and conditions as such attorneys-in-fact may
approve in such attorney-in-fact's sole discretion.
The undersigned hereby gives and grants to each such attorneys-in-fact full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorneys-in-fact, or such attorneys-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.
The undersigned hereby acknowledges that (a) the foregoing attorneys-in-fact
are serving in such capacity at the request of the undersigned; (b) this Limited
Power of Attorney authorizes, but does not require, each such attorneys-in-fact
to act in his or her discretion on information provided to such
attorneys-in-fact without independent verification of such information; (c) any
documents prepared and/or executed by any attorneys-in-fact on behalf of the
undersigned pursuant to this Limited Power of Attorney shall be in such form and
shall contain such information and disclosure as such attorneys-in-fact, in his
or her sole discretion, deems necessary or advisable; (d) neither the Company
nor any attorneys-in-fact assumes (i) any liability for the undersigned's
responsibility to comply with the requirements of the Exchange Act,
(ii) any liability of the undersigned for any failure to comply with such
requirements or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and (e) this Limited Power
of Attorney does not relieve the undersigned from responsibility for compliance
with the undersigned's obligations under the Exchange Act, including, without
limitation, the reporting requirements under Section 16 of the Exchange Act.
This Limited Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked as to any attorneys-in-fact by the undersigned
in a signed writing delivered to such attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 1 day of October, 2016.
__/s/ Louis J. Lavigne, Jr.__
Signature
__Louis J. Lavigne, Jr.__
Print Name